Adittya Arefin

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Inflammatory Response

Gene Expression

Ejection Fraction

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Adittya Arefin, Matthew C Gage
Metformin, Empagliflozin, and Their Combination Modulate Ex-Vivo Macrophage Inflammatory Gene Expression. International journal of molecular sciences 24 (5) (2023)
Adittya Arefin, Matthew C Gage
Metformin, Empagliflozin, and Their Combination Modulate Ex-Vivo Macrophage Inflammatory Gene Expression. International journal of molecular sciences 24 (5) (2023)
Adittya Arefin, Matthew C Gage
Metformin, Empagliflozin, and Their Combination Modulate Ex-Vivo Macrophage Inflammatory Gene Expression. International journal of molecular sciences 24 (5) (2023)
Adittya Arefin, Matthew C Gage
Metformin, Empagliflozin, and Their Combination Modulate Ex-Vivo Macrophage Inflammatory Gene Expression. International journal of molecular sciences 24 (5) (2023)
Ahmed Hossain, Gias Uddin Ahsan, Mohammad Zakir Hossain, Mohammad Anwar Hossain, Zeeba Zahra Sultana, Adittya Arefin, Shah Mohammad Sarwer Jahan, Probal Sutradhar
A prospective longitudinal study with treated hypertensive patients in Northern Bangladesh (PREDIcT-HTN) to understand uncontrolled hypertension and adverse clinical events: A protocol for 5-years follow-up. PloS one 17 (5) (2022)